Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid-Reference-Cited by-同舟云学术

Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid

Published:2016-12 Issue:6 Volume:38 Page:699-705
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Janssen Paddy K. C.,Foudraine Norbert A.,Burgers Desirée M. T.,Neef Kees,le Noble Jos L. M. L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference25 articles.

1. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study;Hoste;Intensive Care Med.,2015

2. Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage;Bohler;Kidney Int Suppl.,1999

3. Renal replacement therapy in acute kidney injury: controversy and consensus;Ronco;Crit Care.,2015

4. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit;Davenport;NDT Plus,2009

5. Clinical review: anticoagulation for continuous renal replacement therapy—heparin or citrate?;Oudemans-van Straaten;Crit Care.,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sub-therapeutic trimethoprim and sulfamethoxazole plasma concentrations during continuous venovenous hemofiltration in a patient with COVID-19 and pulmonary Pneumocystis jirovecii co-infection: A case report;Int. Journal of Clinical Pharmacology and Therapeutics;2023-11-01

2. Extremely high unbound flucloxacillin concentrations in a patient with acute septic renal failure during continuous venovenous hemofiltration: Therapeutic drug monitoring to optimize treatment;Int. Journal of Clinical Pharmacology and Therapeutics;2023-05-01

3. Clearance of Piperacillin–Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation;Therapeutic Drug Monitoring;2023-04

4. Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID‐19‐Associated Acute Respiratory Distress Syndrome;The Journal of Clinical Pharmacology;2022-01-03

5. Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy;Clinical Pharmacokinetics;2021-11-18